References
- Chang, M. N. 2014. Adaptive design theory and implementation using SAS and R (2nd ed.). Boca Raton. Chapman and Hall/CRC.
- Chow, S. C., and M. Chang. 2012. Adaptive design methods in clinical trials. 2nd ed. Boca Raton. Chapman Hall/CRC.
- Friede, T., and M. Kieser. 2006. Sample size recalculation in internal pilot study designs: A review. Biometrical Journal/Biometrische Zeitschrift 48 (4):537–55.
- Gould, L. A., and W. J. Shih. 1992. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Communications in Statistics - Theory and Methods 21 (10):2833–53. doi:10.1080/03610929208830947.
- Lewis, J. A. 1999. Statistical Principles For Clinical Trials (ICH E9): An introductory note on an international guideline. Statistics in Medicine 18 (15):1903–42. doi:10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.0.CO;2-F.
- Lin, M., and S. C. Chow. 2013. Data Monitoring Committees in Adaptive Clinical Trials. Clinical Investigation 3 (7):605–7. doi:10.4155/cli.13.47.
- Proschan, M. A. 2009. Sample size re-estimation in clinical trials. Biometrical Journal. Biometrische Zeitschrift 51 (2):348–57.
- Rencher, A. C., and G. B. Schaalje. 2008. Linear models in statistics. Hoboken, NJ: John Wiley & Sons.
- Schwartz, T. A., and J. S. Denne. 2003. Common threads between sample size recalculation and group sequential procedures. Pharmaceutical Statistics 2 (4):263–71. doi:10.1002/pst.68.
- Shih, W. J., and P. L. Zhao. 1997. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. Statistics in Medicine 16 (17):1913–23. pages doi:10.1002/(SICI)1097-0258(19970915)16:17<1913::AID-SIM610>3.0.CO;2-Z.
- Tharmanathan, P., M. Calvert, J. Hampton, and N. Freemantle. 2008. The use of interim data and data monitoring committee recommendations in randomized controlled trial reports: Frequency, implications and potential sources of bias. BMC Medical Research Methodology 8:12.
- Wu, C. H. 2015. Sample size re-estimation without breaking the blind in clinical trial. Journal of Biopharmaceutical Statistics 25 (5):1114–29. doi:10.1080/10543406.2014.971168.
- Wu, C. H. 2016. Randomized response model versus mixture model in the crossover design for clinical trials. Communications in Statistics - Theory and Methods 45 (15):4611–27. doi:10.1080/03610926.2014.927490.